|
|
 | | | |
- close
- close
- close
- close
These excerpts taken from the ABAX 10-K filed Jun 12, 2009. Cost
of Revenues
The following sets forth, our cost of revenues for fiscal 2009,
2008 and 2007 (in thousands, except percentages):
Cost of revenues includes the costs associated with
manufacturing, assembly, packaging, warranty repairs, test and
quality assurance for our instruments, reagent discs, hematology
reagent kits, coagulation reagents, canine heartworm rapid tests
and manufacturing overhead, including costs of personnel and
equipment associated with manufacturing support.
Fiscal
2009 Compared to Fiscal 2008
Cost of revenues in fiscal 2009 increased by 3%, or
$1.4 million, as compared to fiscal 2008, primarily due to
the following: an increase in the sales volume of
(a) VetScan chemistry analyzers, (b) medical reagent
discs and (c) hematology reagent kits during fiscal 2009.
The increase in cost of revenues was partially offset by a
decrease in the sales volume of (a) Piccolo chemistry
analyzers and (b) hematology instruments during fiscal 2009.
Fiscal
2008 Compared to Fiscal 2007
Cost of revenues in fiscal 2008 increased by 16%, or
$6.1 million, as compared to fiscal 2007, primarily due to
the following: (a) an increase in the sales volume of
medical and veterinary reagent discs during fiscal 2008,
(b) an
Table of Contents
increase in costs associated with manufacturing the VetScan VS2
and Piccolo xpress chemistry analyzers during fiscal 2008 and
(c) the weaker U.S. dollar relative to the Euro
currency during fiscal 2008.
Cost of Revenues The following sets forth, our cost of revenues for fiscal 2009, 2008 and 2007 (in thousands, except percentages):
Cost of revenues includes the costs associated with manufacturing, assembly, packaging, warranty repairs, test and quality assurance for our instruments, reagent discs, hematology reagent kits, coagulation reagents, canine heartworm rapid tests and manufacturing overhead, including costs of personnel and equipment associated with manufacturing support. Fiscal 2009 Compared to Fiscal 2008 Cost of revenues in fiscal 2009 increased by 3%, or $1.4 million, as compared to fiscal 2008, primarily due to the following: an increase in the sales volume of (a) VetScan chemistry analyzers, (b) medical reagent discs and (c) hematology reagent kits during fiscal 2009. The increase in cost of revenues was partially offset by a decrease in the sales volume of (a) Piccolo chemistry analyzers and (b) hematology instruments during fiscal 2009. Fiscal 2008 Compared to Fiscal 2007 Cost of revenues in fiscal 2008 increased by 16%, or $6.1 million, as compared to fiscal 2007, primarily due to the following: (a) an increase in the sales volume of medical and veterinary reagent discs during fiscal 2008, (b) an
Table of Contentsincrease in costs associated with manufacturing the VetScan VS2 and Piccolo xpress chemistry analyzers during fiscal 2008 and (c) the weaker U.S. dollar relative to the Euro currency during fiscal 2008. These excerpts taken from the ABAX 10-K filed Jun 13, 2008. Cost
of Revenues
The following sets forth, our cost of revenues for fiscal 2008,
2007 and 2006 (in thousands, except percentages):
Cost of revenues includes the costs associated with
manufacturing, assembly, packaging, warranty repairs, test and
quality assurance for our instruments, reagent discs and
hematology reagent kits and manufacturing overhead, including
costs of personnel and equipment associated with manufacturing
support.
Fiscal
2008 Compared to Fiscal 2007
Cost of revenues in fiscal 2008 increased by 16%, or
$6.1 million, as compared to fiscal 2007, primarily due to
the following: (a) an increase in the sales volume of
medical and veterinary reagent discs; (b) an increase in
costs associated with manufacturing the VetScan VS2 and Piccolo
xpress chemistry analyzers; and (c) the weaker
U.S. dollar relative to the Euro currency.
Fiscal
2007 Compared to Fiscal 2006
Cost of revenues in fiscal 2007 increased by 31%, or
$9.3 million, as compared to fiscal 2006, primarily due to
the following: (a) an increase in the sales volume of
medical and veterinary instruments and reagent discs and
hematology reagent kits; (b) an increase in costs
associated with manufacturing the VetScan VS2 and Piccolo
xpress; and (c) the weaker U.S. dollar relative to the
Euro currency. As a percentage of total revenues, cost of
Table of Contents
revenues increased in fiscal 2007, as compared to fiscal 2006,
primarily due to costs associated with manufacturing the VetScan
VS2 and Piccolo xpress.
Cost of Revenues The following sets forth, our cost of revenues for fiscal 2008, 2007 and 2006 (in thousands, except percentages):
Cost of revenues includes the costs associated with manufacturing, assembly, packaging, warranty repairs, test and quality assurance for our instruments, reagent discs and hematology reagent kits and manufacturing overhead, including costs of personnel and equipment associated with manufacturing support. Fiscal 2008 Compared to Fiscal 2007 Cost of revenues in fiscal 2008 increased by 16%, or $6.1 million, as compared to fiscal 2007, primarily due to the following: (a) an increase in the sales volume of medical and veterinary reagent discs; (b) an increase in costs associated with manufacturing the VetScan VS2 and Piccolo xpress chemistry analyzers; and (c) the weaker U.S. dollar relative to the Euro currency. Fiscal 2007 Compared to Fiscal 2006 Cost of revenues in fiscal 2007 increased by 31%, or $9.3 million, as compared to fiscal 2006, primarily due to the following: (a) an increase in the sales volume of medical and veterinary instruments and reagent discs and hematology reagent kits; (b) an increase in costs associated with manufacturing the VetScan VS2 and Piccolo xpress; and (c) the weaker U.S. dollar relative to the Euro currency. As a percentage of total revenues, cost of
Table of Contentsrevenues increased in fiscal 2007, as compared to fiscal 2006, primarily due to costs associated with manufacturing the VetScan VS2 and Piccolo xpress. This excerpt taken from the ABAX 10-Q filed Feb 8, 2007. Cost of Revenues The following sets forth, for the periods indicated, our cost of revenues:
Cost of revenues includes the costs associated with manufacturing, assembly, packaging, warranty repairs, test and quality assurance for our instruments, reagent discs and hematology reagents and manufacturing overhead, including costs of personnel and equipment associated with manufacturing support. Three and Nine Months Ended December 31, 2006 Compared with Three and Nine Months Ended December 31, 2005 The increase in cost of revenues in absolute dollars in the three and nine months ended December 31, 2006, as compared to the three and nine months ended December 31, 2005, respectively, was due primarily to (a) an increase in the sales volume of instruments and reagent discs and kits and (b) an increase in costs associated with manufacturing the VetScan VS2 and Piccolo Xpress chemistry analyzers. As a percentage of total revenues, cost of revenues increased in the three and nine months ended December 31, 2006, as compared to the three and nine months ended December 31, 2005, respectively, primarily due to costs associated with manufacturing the VetScan VS2 and Piccolo Xpress chemistry analyzers. This excerpt taken from the ABAX 10-Q filed Nov 9, 2006. Cost of Revenues The following sets forth, for the periods indicated, our cost of revenues:
Cost of revenues includes the costs associated with manufacturing, assembly, packaging, warranty repairs, test and quality assurance for our instruments, reagent discs and hematology reagents and manufacturing overhead, including costs of personnel and equipment associated with manufacturing support. 22 Three and Six Months Ended September 30, 2006 Compared with Three and Six Months Ended September 30, 2005 The increase in cost of revenues in absolute dollars in the three and six months ended September 30, 2006, as compared to the three and six months ended September 30, 2005, was due primarily to (a) an increase in the sales volume of instruments and reagent discs and kits and (b) an increase in costs associated with manufacturing the VetScan VS2 system. As a percentage of total revenues, cost of revenues increased in the three months ended September 30, 2006, as compared to the three months ended September 30, 2005, due to (a) costs associated with manufacturing the VetScan VS2 system and (b) a change in the average selling price of Piccolo systems. This excerpt taken from the ABAX 10-Q filed Aug 9, 2006. Cost of Revenues The following sets forth, for the periods indicated, our cost of revenues:
Cost of revenues includes the costs associated with manufacturing, assembly, package, warranty repairs, test and quality assurance for our instruments, reagent discs and hematology reagents and manufacturing overhead, including costs of personnel and equipment associated with manufacturing support. The increase in cost of revenues in absolute dollars in the three months ended June 30, 2006, as compared to the three months ended June 30, 2005, was primarily due to (i) an increase in the sales volume of instruments and reagent discs and (ii) an increase in costs associated with manufacturing the VetScan VS2 system. | EXCERPTS ON THIS PAGE:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
